Leadership
-
Marc StapleyChief Executive OfficerMarc StapleyChief Executive OfficerMr. Stapley has deep experience in the genomic diagnostics industry, including significant expertise building and leading complex global operations.
-
Rob BraininExecutive Vice President and Chief Business OfficerRob BraininExecutive Vice President and Chief Business OfficerRob Brainin is a seasoned professional with over 20 years of executive life sciences and healthcare experience, and a proven track record of using emerging technologies and data science to improve healthcare.
-
Rebecca ChambersExecutive Vice President and Chief Financial OfficerRebecca ChambersExecutive Vice President and Chief Financial OfficerRebecca Chambers has extensive healthcare leadership experience, previously serving as Chief Financial Officer for Outset Medical, a publicly traded medical technology company focused on reducing dialysis cost and complexity.
-
Corinne DananSenior Vice President, General Manager, Biopharma and IVD ServicesCorinne DananSenior Vice President, General Manager, Biopharma and IVD ServicesCorinne Danan serves as Veracyte’s General Manager, Biopharma, leading the company’s offerings to biopharmaceutical companies. Ms. Danan brings more than 30 years of executive experience in the pharmaceutical, life sciences and healthcare industries, as well as strong leadership in Commercial Operations, to her role at Veracyte.
-
Steven FrenchSenior Vice President and Chief Information OfficerSteven FrenchSenior Vice President and Chief Information OfficerMr. French brings more than 20 years of information and operational leadership experience in the life sciences and technology industries.
-
Fabienne Hermitte, Ph.D.Senior Vice President, Global Quality & Regulatory AffairsFabienne Hermitte, Ph.D.Senior Vice President, Global Quality & Regulatory AffairsFabienne Hermitte, Ph.D., brings deep expertise in clinical diagnostics to her role at Veracyte. She cofounded HalioDx, an immuno-oncology diagnostics company, in 2015. At HalioDx, she led the Regulatory, Quality, Medical Affairs, Clinical Development and Diagnostic Marketing teams prior to the company’s acquisition by Veracyte in August 2021.
-
John Leite, Ph.D.Senior Vice President, General Manager, Pulmonology & Market AccessJohn Leite, Ph.D.Senior Vice President, General Manager, Pulmonology & Market AccessDr. Leite joined Veracyte in September 2022, bringing with him deep diagnostics industry leadership experience. Previously, he served as Chief Business Officer for InterVenn Biosciences, a private-stage diagnostics company, where he was responsible for the company’s commercial, partnership and market access strategy.
-
Annie McGuireExecutive Vice President, General Counsel and Chief People OfficerAnnie McGuireExecutive Vice President, General Counsel and Chief People OfficerAnnie McGuire joined Veracyte in February 2022 as Executive Vice President, General Counsel and Chief People Officer, overseeing all aspects of the company’s legal functions.
-
Tracy MorrisVice President, Global Corporate CommunicationsTracy MorrisVice President, Global Corporate CommunicationsTracy leads the strategy to enhance and extend the global company’s narrative and brand. She oversees integrated marketing communications, public relations and digital marketing to advance the company’s industry leadership and support its business objectives.
-
Tina S. Nova, Ph.D.General Manager, Decipher Urologic CancersTina S. Nova, Ph.D.General Manager, Decipher Urologic CancersTina S. Nova, Ph.D., serves as General Manager, Decipher Urologic Cancers. In this role, she leads all aspects – market development, product marketing, reimbursement, sales and lab operations – of the company’s broad menu of diagnostic tests that are performed in its laboratories, serving physicians and their patients in the United States.
-
Jonathan WygantVice President and Chief Accounting OfficerJonathan WygantVice President and Chief Accounting OfficerJonathan Wygant joined Veracyte in February 2022 as Vice President and Chief Accounting Officer, overseeing all aspects of the company’s global accounting operations, financial reporting and tax functions.